These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

174 related articles for article (PubMed ID: 12182760)

  • 21. PBPK models for the prediction of in vivo performance of oral dosage forms.
    Kostewicz ES; Aarons L; Bergstrand M; Bolger MB; Galetin A; Hatley O; Jamei M; Lloyd R; Pepin X; Rostami-Hodjegan A; Sjögren E; Tannergren C; Turner DB; Wagner C; Weitschies W; Dressman J
    Eur J Pharm Sci; 2014 Jun; 57():300-21. PubMed ID: 24060672
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Pharmacokinetics and pharmacodynamics of propranolol in hypertensive patients after sublingual administration: systemic availability.
    Mansur AP; Avakian SD; Paula RS; Donzella H; Santos SR; Ramires JA
    Braz J Med Biol Res; 1998 May; 31(5):691-6. PubMed ID: 9698776
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Pharmacokinetics of D-propranolol following oral, intra-arterial and intraportal administration: contrasting effects of oral glucose pretreatment.
    Chow HH; Lalka D
    Biopharm Drug Dispos; 1993 Apr; 14(3):217-31. PubMed ID: 8490110
    [TBL] [Abstract][Full Text] [Related]  

  • 24. In vivo non-linear intestinal permeability of celiprolol and propranolol in conscious dogs: evidence for intestinal secretion.
    Lipka E; Spahn-Langguth H; Mutschler E; Amidon GL
    Eur J Pharm Sci; 1998 Jan; 6(1):75-81. PubMed ID: 16256710
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Saturable first-pass kinetics of propranolol.
    Keller F; Kunzendorf U; Walz G; Haller H; Offermann G
    J Clin Pharmacol; 1989 Mar; 29(3):240-5. PubMed ID: 2723110
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Model-Based Analysis of Biopharmaceutic Experiments To Improve Mechanistic Oral Absorption Modeling: An Integrated in Vitro in Vivo Extrapolation Perspective Using Ketoconazole as a Model Drug.
    Pathak SM; Ruff A; Kostewicz ES; Patel N; Turner DB; Jamei M
    Mol Pharm; 2017 Dec; 14(12):4305-4320. PubMed ID: 28771009
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Controlled transdermal delivery of propranolol using HPMC matrices: design and in-vitro and in-vivo evaluation.
    Verma PR; Iyer SS
    J Pharm Pharmacol; 2000 Feb; 52(2):151-6. PubMed ID: 10714944
    [TBL] [Abstract][Full Text] [Related]  

  • 28. A generic, cross-chemical predictive PBTK model with multiple entry routes running as application in MS Excel; design of the model and comparison of predictions with experimental results.
    Jongeneelen FJ; Berge WF
    Ann Occup Hyg; 2011 Oct; 55(8):841-64. PubMed ID: 21998005
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Design and evaluation of a bioadhesive film for transdermal delivery of propranolol hydrochloride.
    Rasool BK; Aziz US; Sarheed O; Rasool AA
    Acta Pharm; 2011 Sep; 61(3):271-82. PubMed ID: 21945906
    [TBL] [Abstract][Full Text] [Related]  

  • 30. PBPK modeling of intestinal and liver enzymes and transporters in drug absorption and sequential metabolism.
    Fan J; Chen S; Chow EC; Pang KS
    Curr Drug Metab; 2010 Nov; 11(9):743-61. PubMed ID: 21189137
    [TBL] [Abstract][Full Text] [Related]  

  • 31. A new physiologically based pharmacokinetic model for the prediction of gastrointestinal drug absorption: translocation model.
    Ando H; Hisaka A; Suzuki H
    Drug Metab Dispos; 2015 Apr; 43(4):590-602. PubMed ID: 25616403
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Advances and challenges in PBPK modeling--Analysis of factors contributing to the oral absorption of atazanavir, a poorly soluble weak base.
    Berlin M; Ruff A; Kesisoglou F; Xu W; Wang MH; Dressman JB
    Eur J Pharm Biopharm; 2015 Jun; 93():267-80. PubMed ID: 25872159
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Pharmacokinetic evaluation of conventional and controlled release dosage form of propranolol.
    Das SK; Chattaraj SC
    Arzneimittelforschung; 1990 Jul; 40(7):752-4. PubMed ID: 2222550
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Decreased absorption as a possible cause for the lower bioavailability of a sustained-release propranolol.
    Takahashi H; Ogata H; Warabioka R; Kashiwada K; Ohira M; Someya K
    J Pharm Sci; 1990 Mar; 79(3):212-5. PubMed ID: 2338628
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Parameters for pyrethroid insecticide QSAR and PBPK/PD models for human risk assessment.
    Knaak JB; Dary CC; Zhang X; Gerlach RW; Tornero-Velez R; Chang DT; Goldsmith R; Blancato JN
    Rev Environ Contam Toxicol; 2012; 219():1-114. PubMed ID: 22610175
    [TBL] [Abstract][Full Text] [Related]  

  • 36. In Vitro Skin Retention and Drug Permeation through Intact and Microneedle Pretreated Skin after Application of Propranolol Loaded Microemulsions.
    Kelchen MN; Brogden NK
    Pharm Res; 2018 Oct; 35(12):228. PubMed ID: 30302631
    [TBL] [Abstract][Full Text] [Related]  

  • 37. In silico predictions of gastrointestinal drug absorption in pharmaceutical product development: application of the mechanistic absorption model GI-Sim.
    Sjögren E; Westergren J; Grant I; Hanisch G; Lindfors L; Lennernäs H; Abrahamsson B; Tannergren C
    Eur J Pharm Sci; 2013 Jul; 49(4):679-98. PubMed ID: 23727464
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Progress in methodology of establishing physiologically based pharmacokinetic models].
    Jin YW; Ma YM
    Yao Xue Xue Bao; 2014 Jan; 49(1):16-22. PubMed ID: 24783500
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Development of a Whole-Body Physiologically Based Pharmacokinetic Approach to Assess the Pharmacokinetics of Drugs in Elderly Individuals.
    Schlender JF; Meyer M; Thelen K; Krauss M; Willmann S; Eissing T; Jaehde U
    Clin Pharmacokinet; 2016 Dec; 55(12):1573-1589. PubMed ID: 27351180
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Mass Spectrometry Imaging proves differential absorption profiles of well-characterised permeability markers along the crypt-villus axis.
    Nilsson A; Peric A; Strimfors M; Goodwin RJA; Hayes MA; Andrén PE; Hilgendorf C
    Sci Rep; 2017 Jul; 7(1):6352. PubMed ID: 28743866
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.